A former W.L. Gore & Associates Inc. engineer facing accusations that he stole trade secrets from the high-tech fabric company was ordered to home confinement on Monday following his arrest while allegedly attempting to flee the country, according to documents filed in Delaware district court.
Glenmark Generics Ltd. filed a complaint against Sanofi-Aventis U.S. LLC and Ferring BV in New Jersey federal court Friday, asking the court to help speed up regulatory approval of a generic version of an antidiuretic drug by affirming that it would not infringe on a Sanofi patent.
A federal judge ruled Tuesday that a lawsuit by Vermont's attorney general accusing so-called patent troll MPHJ Technology Investments LLC of violating state consumer protection laws must be heard in state court, rejecting MPHJ's claim that the case hinged on federal patent law.
A Washington federal judge shot down Medtrica Solutions Ltd. and Steris Corp.’s attempt to recover attorneys’ fees from Cygnus Medical LLC for an allegedly frivolous patent infringement suit over an endoscope precleaning kit, ruling Wednesday that Cygnus’ claims were not baseless.
A Massachusetts federal judge rejected six bids by Centocor Ortho Biotech Inc. to toss allegations that its rheumatoid arthritis drug Simponi infringes Abbott Biotechnology Ltd.’s Humira patents, ruling Wednesday that the Johnson & Johnson unit hasn’t shown the asserted patent claims are invalid.
Sandoz Inc. can't trim a claim from a patent suit over a proposed generic version of United Therapeutics Corp.’s hypertension drug Remodulin, after a New Jersey federal judge Wednesday found basis for UTC’s claim that Sandoz induced physicians to infringe the patent.
The U.S. International Trade Commission has ruled that MaxLite Inc. violated a consent order in which it agreed to stop importing fluorescent dimmer technology that infringed a Neptun Light Inc. patent, according to a Federal Register notice posted Wednesday.
Mars Inc. on Tuesday accused competitor The Hershey Co. of using a “campaign of deception” to edge out its Maltesers candy line through its ownership of a confusingly similar trademark to make way for its competing line of Whoppers candy, according to Virginia federal court filings.
A California federal judge on Monday refused to give Metro-Goldwyn-Mayer Studios Inc. expedited discovery in its lawsuit accusing NBCUniversal Media LLC of plotting a knockoff James Bond movie, saying Universal's early-stage film project didn't pose a sufficiently immediate threat to MGM.
The European Medicines Agency said on Wednesday that vials of F. Hoffmann-La Roche Ltd.’s breast and stomach cancer medicine Herceptin, thought to have been stolen from hospitals in Italy, have been tampered with and reintroduced into the market in some countries.
A Delaware federal judge released a written opinion Tuesday explaining that he had on Friday barred most U.S. sales of Medtronic Inc.'s allegedly infringing heart valve systems because rival Edwards Lifesciences AG was likely to win on the merits — a ruling Medtronic has already appealed to the Federal Circuit.
A California judge on Tuesday approved Sheppard Mullin Richter & Hampton LLP's plan to auction off patents owned by ex-client Bluways Inc., which had failed to pay the firm $884,978 in fees per an agreement, acknowledging that the law firm hasn't found likely buyers and might have to purchase the patents itself.
In an apparent first for the new America Invents Act review proceedings, the U.S. Patent and Trademark Office on Friday affirmed every claim of two motion control software patents owned by Roy-G-Biv Corp. after completing an inter partes review.
Samsung Electronics Co. Ltd.’s patent experts shot holes Tuesday in Apple Inc.’s allegations that Samsung smartphones infringe five iPhone patents, telling a California federal jury that patents on the iPhone’s universal search, autocorrect and slide-to-unlock features are invalid because other companies invented them first.
With the filing of more than 1,200 petitions challenging patents under the America Invents Act's new proceedings, parties on both sides are making many common and avoidable mistakes, the judges dealing with those cases said at a forum Tuesday.
Full-service law firm FisherBroyles LLP slammed Juris Law Group with a trademark suit in Georgia federal court Tuesday, accusing its fellow alternative model firm of infringing a mark for “the next generation law firm,” which FisherBroyles uses in its logo and JLG uses as a slogan.
The U.S. Patent Trial and Appeal Board said on Tuesday that it is not a “death squad” attempting to invalidate every patent undergoing administrative review, noting that only a small fraction of patents under inter partes review end up being completely invalidated.
Seventh Circuit Chief Judge Diane Wood talks to Law360 about managing a court in crisis, surviving two U.S. Supreme Court near-misses, and tailoring crafty dissenting opinions that can change the mind of even the staunchest of ideological opponents.
Two piracy group members admitted their roles in separate schemes to distribute copyrighted Android programs in Georgia federal court this week, the latest conviction in the government's ongoing mobile app piracy crackdown, according to authorities.
Rohm & Haas must face Title VII allegations that it retaliated against a former employee who started a competing research company, but it is not liable for claims that it breached a settlement agreement reached when she first left the company, a Pennsylvania federal judge ruled Monday.
The Ninth Circuit's recent decision in Herb Reed Enterprises LLC v. Florida Entertainment Management Inc. has shifted the balance against plaintiffs seeking a preliminary injunction in the trademark context to be in line with the trend in patent cases. The party seeking an injunction must proffer some evidence of irreparable harm, and can no longer rely on the presumption, say Beth Goldman and Daniel Justice of Orrick Herrington & Sutcliffe LLP.
The new world of 3-D printing raises many new and old questions about how to use intellectual property as part of a business model. Utility patents, copyrights, design patents and trade dress offer relevant, adaptable protection options, and each has its own set of pros, cons and considerations, say Paige Stradley and George Lewis of Merchant & Gould.
Jewel litigation has been filed after every major law firm bankruptcy in the past 10 years, including Lyon & Lyon, Brobeck, Coudert, Thelen, Heller and Howrey. These lawsuits have produced years of litigation, with similar suits expected in the Dewey bankruptcy. Despite the legal uncertainties surrounding such claims, hiring firms can take steps now to minimize their Jewel risk for any lateral hire, say attorneys with Arnold & Porter LLP.
Some of the early commentary on the Eastern District of Texas' new alternative case management procedure for patent cases focused on how it might be “bad news” for some nonpracticing entities taking that approach. A deeper dive, however, reveals that, while Track B might benefit parties accused of infringing a patent in some situations, in others, it might even benefit parties asserting their patents, say attorneys with Finnegan Henderson Farabow Garrett & Dunner LLP.
The Trademark Trial and Appeal Board has recently held that applicants did not possess an objectively supported “bona fide intent,” when there was little or no documentation to evidence a plan to use the mark in commerce at the time of application. Such scrutiny is at odds with the Lanham Act and U.S. Patent and Trademark Office regulations, say Judith Grubner and Kathleen Waitzman of Arnstein & Lehr LLP.
While the actual breaches are unknown, Heartbleed has the potential to expose all of a lawyer's files stored or transmitted online. The bug raises professional responsibility questions and offers confirmation of the greatest anxieties that the legal industry has about online practice. In fact, the timing is poor for many legal tech providers, following a general industry warming to cloud offerings, says David Houlihan of Blue Hill Research Inc.
The Patent Trial and Appeal Board's recent decision in Ex Parte Gross sets forth its “preferred verbiage” for alternative claim limitations. While the PTAB indicated that “and/or” is acceptable, but disfavored, a patentee should take care when following this guidance, as the courts have read such claims much more narrowly, say Clifford Ulrich and Michael Turner of Kenyon & Kenyon LLP.
Are contractual agreements by patent licensees not to challenge the validity of a licensed patent enforceable? Despite the regularity with which patentees confront this question, the answer is surprisingly unclear, say Margaret Sampson, Ajeet Pai and Jeff Gritton of Vinson & Elkins LLP.
In Europe, patent holders can obtain compensation for regulatory delays in bringing a new medicinal product to market via the award of a supplementary protection certificate. The system was intended to be clear and easy to implement, but after more than 20 years, courts and practitioners remain unsure as to how key terms in the legislation are to be interpreted, despite three recent EU Court of Justice judgments, say Matthew Jones and Andrew Sharples of EIP.
Why do the majority of speakers get polite claps at the end of their talks while a few select others receive rousing applause? Having given more than 375 presentations to legal groups, bar associations, Fortune 500 companies and corporate gatherings, I’ve learned a few things about what not to do. Remember, great speakers don’t tell “war stories.” They don’t even give examples from their own practice, says Michael Rubin of McGlinchey Stafford PLLC.